Jose Manuel Valdivielso Revilla

Ortiz A; Ferro CJ; Balafa O; Burnier M; Ekart R; Halimi JM; Kreutz R; Mark PB; Persu A; Rossignol P; Ruilope LM; Schmieder RE; Valdivielso JM; Del Vecchio L; Zoccali C; Mallamaci F; Sarafidis P; European Renal and Cardiovascular Medicine (EURECA-m) working group of the Europ

Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.

NEPHROLOGY DIALYSIS TRANSPLANTATION 38 10-25. 23/01/2023.

[doi:10.1093/ndt/gfab167]

González LM; Robles NR; Mota-Zamorano S; Valdivielso JM; González-Rodríguez L; López-Gómez J; Gervasini G

Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients.

SCIENTIFIC REPORTS 13 1253-1253. 23/01/2023.

[doi:10.1038/s41598-022-27343-z]

Matsushita K; Kaptoge S; Hageman SH; Sang Y; Ballew SH; Grams ME; Surapaneni A; Sun L; Arnlov J; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Jassal SK; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sairenchi T; Schaeffner E; Schneider MP; Shalev V; Shlipak MG; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AYM; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Dorresteijn JA; Di Angelantonio E; Visseren FL; Pennells L; Coresh J

Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 30 8-16. 11/01/2023.

[doi:10.1093/eurjpc/zwac176]

Sánchez E; Sánchez M; López-Cano C; Bermúdez-López M; Valdivielso JM; Farràs-Sallés C; Pamplona R; Torres G; Mauricio D; Castro E; Fernández E; Lecube A

Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project.

Nutrients 15 -. 01/01/2023.

[doi:10.3390/nu15010203]

Mota-Zamorano, S; Gonzalez, LM; Robles, NR; Valdivielso, JM; Arevalo-Lorido, JC; Lopez-Gomez, J; Gervasini, G

Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy.

ANNALS OF MEDICINE 54 3039-3051. 01/12/2022.

[doi:10.1080/07853890.2022.2138531]

Navarro-Gonzalez, JF; Mora-Fernandez, C; Diaz-Tocados, JM; Bozic, M; Bermudez-Lopez, M; Martin, M; Valdivielso, JM

Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease.

Nutrients 14 -. 16/11/2022.

[doi:10.3390/nu14224842]

Bover, J; Trinidad, P; Jara, A; Soler-Majoral, J; Martin-Malo, A; Torres, A; Frazao, J; Urena, P; Dusso, A; Arana, C; Graterol, F; Romero, G; Troya, M; Samaniego, D; D'Marco, L; Valdivielso, JM; Fernandez, E; Arenas, MD; Torregrosa, V; Navarro-Gonzalez, JF; Lloret, MJ; Ballarin, JA; Bosch, RJ; Gorriz, JL; de Francisco, ALM; Gutierrez, O; Ara, J; Felsenfeld, A; Canalejo, A; Almaden, Y

Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell

Nefrologia 42 645-655. 01/11/2022.

[doi:10.1016/j.nefro.2021.12.005]

Quiroga, B; Ramos, PM; Horrillo, AS; Ortiz, A; Valdivieso, JM; Carrero, JJ

Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease

CLINICAL KIDNEY JOURNAL 15 1705-1712. 01/09/2022.

[doi:10.1093/ckj/sfac073]

Bermúdez-López M; Martí-Antonio M; Castro-Boqué E; Bretones MDM; Farràs C; Torres G; Pamplona R; Lecube A; Mauricio D; Valdivielso JM; Fernández E

Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study.

Frontiers in Cardiovascular Medicine 9 895917-895917. 14/07/2022.

[doi:10.3389/fcvm.2022.895917]

Rayego-Mateos, Sandra; Dolade, Nuria; Garcia-Carrasco, Alicia; Diaz-Tocados, JM; Ibarz, Merce; Valdivielso, JM

The Increase in FGF23 Induced by Calcium Is Partially Dependent on Vitamin D Signaling.

Nutrients 14 -. 22/06/2022.

[doi:10.3390/nu14132576]

Gonzalez, L; Robles, N; Mota-Zamorano, S; Arevalo-Lorido, J; Valsivielso, J; Lopez-Gomez, J; Gervasini, G

Genetic variability in phospholipase genes affect nephrosclerosis risk and associated cardiovascular outcomes

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 26-26. 01/06/2022.

Mota-Zamorano, S; Gonzalez, L; Gonzalez-Rodriguez, L; Robles, N; Valdivielso, J; Arevalo-Lorido, J; Lopez-Gomez, J; Gervasini, G

Polymorphisms in glucose homeostasis candidate genes affect cardiovascular outcomes of patients with diabetic nephropathy

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 96-97. 01/06/2022.